在外围T细胞淋巴瘤的治疗挑战
Yunpeng Luan1,2, Xiang Li3, Yunqi Luan4
1The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, 650021, China. luanyunpeng@ynutcm.edu.cn.
Molecular cancer
|January 4, 2024
概括
周围T细胞淋巴瘤 (PTCL) 是一种具有挑战性的癌症. 本综述探讨了PTCL如何发展耐药性,并讨论了针对复发或耐药PTCL的当前治疗方法和正在进行的临床试验.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
背景情况:
- 周围T细胞淋巴瘤 (PTCL) 是一种罕见的,异质的血液性恶性瘤,与B细胞瘤相比,对它的理解有限.
- 许多患者在晚期被诊断出来,耐药性导致复发性或耐火性PTCL (r/r PTCL) 的不良结果.
研究的目的:
- 审查PTCL中治疗耐药性的机制.
- 讨论当前治疗策略及其局限性.
- 总结正在进行的r/r PTCL临床试验.
主要方法:
- 对PTCL抵抗机制的文献综述.
- 对现有和新兴药物疗法的分析.
- 从正在进行的临床试验中汇编数据.
主要成果:
- PTCL治疗耐药性受到瘤异质性,瘤微环境和异常信号通路的影响.
- 由于各种抗药机制,现有的药物面临着挑战.
- 目前正在进行几项临床试验,以改善r/r PTCL治疗结果.
结论:
- 了解PTCL耐药机制对于开发有效疗法至关重要.
- 向瘤异质性,微环境和信号通路提供了潜在的治疗途径.
- 正在进行的临床试验对于推进治疗决策和改善r/r PTCL患者的治疗结果至关重要.
关键词:
在ALCL和ALCL之间.临床试验临床试验是指临床试验的临床试验.药物耐药性 药物耐药性 药物耐药性在白血病中,白血病.淋巴瘤是一种淋巴瘤.在这里,NHL NHL NHL NHL.在PTCL中,PTCL就是PTCL.耐火的 耐火的 耐火的复发复发的情况所有的T-ALL.在此之前,TME的更多相关视频
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.4K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.4K
相关概念视频
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K